![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Active Filter(s):
Details:
The collaboration aims to co-develop cutting-edge AI modules for biotherapeutic drug discovery leveraging BioMap’s AI platform to discover novel targets and design biologics through a deep understanding of proteins.
Lead Product(s): Undisclosed
Therapeutic Area: Immunology Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Large molecule
Partner/Sponsor/Collaborator: Sanofi
Deal Size: $1,000.0 million Upfront Cash: $10.0 million
Deal Type: Collaboration October 10, 2023